Solving the Alzheimer’s Riddle: Why We’ve Never Been Closer
With the expected rise in patients diagnosed with Alzheimer’s, we now have over $900 million in funding available for research, but is all of that research actually helping us come closer to finding a cure for Alzheimer’s? As those with loved ones impacted by the disease watch and wait with bated breath, a variety of trials – some with greater success than others – seem to be pointing to a similar conclusion: rather than one silver bullet to cure Alzheimer’s, a combination of medications and lifestyle changes will likely be needed to win the battle.
Of particular interest, one of the latest studies that has results expected sometime this year is showing exciting results in lowering the brain’s beta-amyloid levels – the protein thought to play a role in destroying the neuron. A study of vaccines is also underway, along with a trial to track changes in the brain as a preventative measure for those who are at heightened risk due to certain gene mutations, but who are not yet exhibiting symptoms.
Ronald Petersen, the director of the Mayo Clinic Study of Aging and Alzheimer’s Disease Research Center said, “It’s a breathholding time for the field; I think the field is in so much of a need of some kind of positive indication that we are on the right track. I think we can have a little more optimism about drug trials that are coming down the road.”
CareWorks Health Services, as always, is keeping a close eye on Alzheimer’s research developments, and as the search for a cure continues, we’re here to help with Alzheimer’s disease management. If you have a loved one with Alzheimer’s disease, contact us any time if you would like a partner in Alzheimer’s care.